Cold agglutinin disease and COVID-19 requiring therapeutic plasma exchange

9Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

A 70-year-old man with known cold autoimmune haemolytic anaemia was referred to the emergency department with increased shortness of breath on exertion. He had been confirmed positive for non-variant COVID-19 infection 1 week earlier based on nasopharyngeal swab PCR assay. CT thorax demonstrated diffuse patchy bilateral ground glass opacities, consistent with COVID-19 pneumonia. Bloodwork demonstrated severe cold agglutinin mediated haemolytic anaemia. To help stabilise the patient, he was transferred to a tertiary care hospital for urgent therapeutic plasma exchange. Key supportive therapy included folic acid supplementation, ensuring the patient was kept warm and warmed infusions including transfusions via the apheresis machine. The patient made a good recovery following plasma exchange, and his haemoglobin levels remained stable by discharge.

Cite

CITATION STYLE

APA

Ahmed, Y., Khandelwal, A., & Walker, L. (2021). Cold agglutinin disease and COVID-19 requiring therapeutic plasma exchange. BMJ Case Reports, 14(7). https://doi.org/10.1136/bcr-2021-244227

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free